Table 2.
The characteristics of study population according to non-alcoholic fatty liver disease (NAFLD) status and gender (means ± standard deviation).
| Male (n = 900) | Female (n = 592) | |||
| Non-NAFLD | NAFLD | Non-NAFLD | NAFLD | |
| Case count | 743 | 157 | 520 | 72 |
| Age (years) | 50.92 ± 4.66 | 50.32 ± 4.29 | 50.69 ± 4.71∗ | 52.14 ± 4.87 |
| BMI (kg/m2) | 24.74 ± 2.94∗∗ | 25.96 ± 2.69 | 23.64 ± 2.79∗∗ | 26.09 ± 2.74 |
| WC (cm) | 87.15 ± 8.45∗∗ | 91.07 ± 7.00 | 79.80 ± 7.96∗∗ | 87.27 ± 6.35 |
| WHR | 0.89 ± 0.05∗∗ | 0.91 ± 0.04 | 0.84 ± 0.07∗∗ | 0.88 ± 0.05 |
| SBP (mm Hg) | 131.65 ± 17.05∗∗ | 135.95 ± 17.25 | 127.43 ± 17.22∗∗ | 133.44 ± 16.31 |
| DBP (mm Hg) | 82.53 ± 13.27∗∗ | 86.07 ± 14.12 | 77.25 ± 12.19∗∗ | 82.59 ± 11.32 |
| FG (mmol/L) | 6.17 ± 1.90 | 6.30 ± 2.51 | 5.73 ± 0.89∗∗ | 6.47 ± 1.73 |
| HbA1c (%) | 5.26 ± 1.40∗ | 6.18 ± 0.95 | 6.83 ± 1.53∗ | 7.32 ± 1.09 |
| TG (mmol/L) | 1.88 ± 1.54∗ | 2.39 ± 3.11 | 1.25 ± 0.83∗∗ | 1.96 ± 1.64 |
| TC (mmol/L) | 5.14 ± 0.87 | 5.23 ± 1.48 | 5.17 ± 0.84∗∗ | 5.62 ± 0.95 |
| HDL-C (mmol/L) | 1.32 ± 0.44∗∗ | 1.16 ± 0.29 | 1.54 ± 0.38∗∗ | 1.33 ± 0.26 |
| LDL-C (mmol/L) | 3.28 ± 0.86 | 3.43 ± 0.87 | 3.16 ± 0.84∗∗ | 3.60 ± 0.78 |
| SUA (μmol/L) | 358.96 ± 74.66 | 369.86 ± 88.94 | 269.63 ± 56.80∗∗ | 295.40 ± 64.52 |
| ALT (U/L) | 27.09 ± 15.50∗∗ | 34.88 ± 18.21 | 20.78 ± 12.86∗∗ | 26.84 ± 14.73 |
| AST (U/L) | 24.68 ± 8.82∗ | 26.27 ± 8.56 | 23.01 ± 7.40 | 23.34 ± 7.07 |
∗
P < .05, variable means in male or female with and without NAFLD.
∗∗
P < .01, variable means in male or female with and without NAFLD.
ALT = alanine aminotransferase, AST = asparagine aminotransferase, BMI = body mass index, DBP = diastolic blood pressure, FG = fasting glucose, HbA1c = Glycosylated haemoglobin, HDL-C = high density lipoprotein-cholesterol, LDL-C = low density lipoprotein- cholesterol, NAFLD = nonalcoholic fatty liver disease, SBP = systolic blood pressure, SUA = serum uric acid, TC = total cholesterol, TG = triglycerides, WC = waist circumference, WHR = waist-hip ratio.